Home » Topics » Regulatory

Regulatory
RSS

FDA approves first vaccine for prevention of invasive pneumococcal disease in infants and toddlers

Feb. 18, 2000

Pharmacyclics' texaphyrins now claimed for use in macrophage-mediated conditions

Feb. 17, 2000

Transmucosal clemastine under study at Nastech for motion sickness

Feb. 16, 2000

Bio-Technology General obtains first marketing approval worldwide for HBV vaccine

Feb. 15, 2000

Ophthalmic antibacterial on the way to market in Japan

Feb. 15, 2000

FDA approves Actimmune for treatment of osteopetrosis

Feb. 14, 2000

Preclinical studies support potential new indication for tamsulosin

Feb. 14, 2000

Nastech claims formulations of sildenafil for nasal delivery

Feb. 11, 2000

Improved topical formulations of aciclovir developed at Recordati

Feb. 11, 2000

FDA approves Lotronex for IBS in women

Feb. 10, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.